KMC Speciality

Market Cap: Micro Cap
Industry: Hospital
ISIN: INE879K01018
NSEID:
BSEID: 524520

INR

76.39

-0.29 (-0.38%)

BSENSE

Dec 05

BSE+NSE Vol: 8.97 k

{
  "main_header": {
    "sid": 301845,
    "name": "KMC Speciality",
    "stock_name": "KMC Speciality",
    "full_name": "KMC Speciality Hospitals (India) Ltd",
    "name_url": "stocks-analysis/kmc-speciality",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "76.39",
    "chg": -0.29,
    "chgp": "-0.38%",
    "dir": -1,
    "prev_price": "76.68",
    "mcapval": "1,245.81 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524520,
    "symbol": "",
    "ind_name": "Hospital",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE879K01018",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "8.97 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kmc-speciality-301845-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "KMC Speciality Sees Revision in Market Evaluation Amid Positive Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kmc-speciality-upgraded-to-buy-by-marketsmojo-on-strong-financial-and-valuation-metrics-3737079",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/KMCSpeciality_mojoScore_3737079.png",
        "date": "2025-11-30 10:24:53",
        "description": "KMC Speciality has experienced a revision in its market evaluation, reflecting recent developments across its financial and operational parameters. The hospital sector stock, classified as a microcap, has demonstrated notable financial trends and valuation characteristics that have influenced this shift in market assessment."
      },
      {
        "title": "Why is KMC Speciality falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-kmc-speciality-fallingrising-3726646",
        "imagepath": "",
        "date": "2025-11-25 00:35:13",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>The stock has been under pressure for the past three consecutive trading sessions, cumulatively losing 7.92% in value. This decline is significant when compared to the benchmark Sensex, which remained almost flat over the past week with a marginal 0.06% gain. The underperformance is further emphasised by the stock’s 7.31% loss over the last seven days, a stark contrast to the Sensex’s stability.</p>\n<p>Intraday trading on 24-Nov saw the stock touch a low of ₹73.50, representing a 5.17% drop from previous levels. The weighted average price indicates that a larger volume of shares exchanged hands closer to this lower price point, suggesting selling pressure dominated the session. This pattern often signals that sellers are more aggressiv..."
      },
      {
        "title": "KMC Speciality Hospitals (India) Sees Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kmc-speciality-hospitals-india-sees-mixed-technical-signals-amid-price-momentum-shift-3723640",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/KMCSpecialityHo_technicaldot_3723640.png",
        "date": "2025-11-24 08:01:15",
        "description": "KMC Speciality Hospitals (India) has experienced a nuanced shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. The stock’s recent price momentum and technical indicators such as MACD, RSI, and moving averages reveal a landscape that demands careful analysis for investors tracking this hospital sector player."
      },
      {
        "title": "KMC Speciality Hospitals Reports Strong Financial Metrics and Operational Effectiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kmc-speciality-hospitals-financial-trend-improves-from-flat-to-very-positive-amid-strong-performance-3701189",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/KMCSpecialityHo_fintrenddot_3701189.png",
        "date": "2025-11-14 11:00:48",
        "description": "KMC Speciality Hospitals has reported notable financial improvements for the quarter ending September 2025, with record net sales of Rs 74.90 crore and a profit before tax of Rs 13.50 crore. The company maintains a low debt-equity ratio of 0.47, reflecting stability and effective management."
      },
      {
        "title": "KMC Speciality Hospitals Q2 FY26: Robust Growth Momentum Continues Despite Margin Pressures",
        "link": "https://www.marketsmojo.com/news/result-analysis/kmc-speciality-hospitals-q2-fy26-robust-growth-momentum-continues-despite-margin-pressures-3712266",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/KMCSpecialityHo_quaterlyResult_3712266.png",
        "date": "2025-11-14 09:21:57",
        "description": "KMC Speciality Hospitals (India) Ltd., the Tiruchirappalli-based healthcare provider, reported a standout performance for Q2 FY26, with net profit surging 43.81% quarter-on-quarter to ₹10.84 crores from ₹7.54 crores in Q1 FY26. On a year-on-year basis, profitability more than doubled, registering a remarkable 179.38% increase from ₹3.88 crores in Q2 FY25. The company's shares responded positively, advancing 2.06% to ₹79.75 on November 14, 2025, as investors digested the strong operational performance that underscored the hospital chain's expanding footprint in southern India."
      },
      {
        "title": "Is KMC Speciality overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kmc-speciality-overvalued-or-undervalued-3700033",
        "imagepath": "",
        "date": "2025-11-14 08:07:44",
        "description": "As of 13 November 2025, KMC Speciality has moved from a fair to an attractive valuation grade. The company is currently considered undervalued, especially when compared to its peers in the hospital industry. Key ratios include a PE Ratio of 41.88, an EV to EBITDA of 19.70, and a ROE of 18.51%. \n\nIn comparison to peers, Apollo Hospitals has a significantly higher PE Ratio of 64.07, while Max Healthcare is even more expensive at 88.67. This suggests that KMC Speciality offers a more favorable valuation relative to its competitors. Additionally, KMC's recent stock performance has outpaced the Sensex, with a 1-week return of 12.88% compared to the Sensex's 1.40%, reinforcing the attractiveness of its current valuation...."
      },
      {
        "title": "How has been the historical performance of KMC Speciality?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-kmc-speciality-3698974",
        "imagepath": "",
        "date": "2025-11-13 23:18:29",
        "description": "Answer:\nThe historical performance of KMC Speciality shows a steady growth in net sales, reaching 231.60 Cr in March 2025, up from 177.18 Cr in March 2024 and 155.76 Cr in March 2023. Total operating income has followed a similar upward trend, increasing to 231.60 Cr in March 2025 from 177.18 Cr in the previous year. The company's total expenditure, excluding depreciation, also rose to 174.71 Cr in March 2025, compared to 129.79 Cr in March 2024. Operating profit, excluding other income, improved to 56.89 Cr in March 2025, while profit before tax decreased to 31.60 Cr from 40.56 Cr in March 2024. Profit after tax also saw a decline to 21.43 Cr in March 2025 from 30.38 Cr in March 2024. The earnings per share (EPS) decreased to 1.31 in March 2025 from 1.86 in March 2024. \n\nIn terms of assets and liabilities, total assets increased to 286.00 Cr in March 2025 from 263.72 Cr in March 2024, while total liabiliti..."
      },
      {
        "title": "Is KMC Speciality overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-kmc-speciality-overvalued-or-undervalued-3696019",
        "imagepath": "",
        "date": "2025-11-13 08:08:23",
        "description": "As of 12 November 2025, KMC Speciality's valuation grade has moved from attractive to fair, indicating a shift in its perceived market value. The company appears to be fairly valued at this time, with a PE ratio of 54.51, an EV to EBITDA ratio of 22.49, and a ROE of 14.27%. In comparison to its peers, Apollo Hospitals is rated attractive with a higher PE of 64.52, while Narayana Hrudaya is considered expensive with a PE of 45.49.\n\nDespite the fair valuation, KMC Speciality's high PE ratio suggests that investors are paying a premium for its earnings relative to its peers. The stock has shown a strong performance over the past five years, with a return of 302.98%, significantly outpacing the Sensex's 94.82% return in the same period. This long-term growth may support the current valuation, but the recent downgrade in the grade suggests caution moving forward...."
      },
      {
        "title": "KMC Speciality Hospitals Adjusts Valuation Amidst Mixed Industry Performance Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kmc-speciality-hospitals-valuation-grade-downgraded-from-attractive-to-fair-3695989",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/KMCSpecialityHo_valuationdot_3695989.png",
        "date": "2025-11-13 08:00:29",
        "description": "KMC Speciality Hospitals has recently adjusted its valuation, with its stock price reflecting a significant increase. Over the past year, the company has faced challenges, underperforming compared to the Sensex. Key financial metrics indicate operational efficiency, while comparisons with peers reveal diverse performance within the hospital industry."
      }
    ],
    "total": 604,
    "sid": "301845",
    "stock_news_url": "https://www.marketsmojo.com/news/kmc-speciality-hospitals-india-301845"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "26-Nov-2025",
      "details": "Newspaper publication regarding special window for re-lodgement of transfer request of physical shares of the Company",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "26-Nov-2025",
      "details": "Investor presentation for the quarter and half year ended 30th September 2025.",
      "source": "BSE"
    },
    {
      "caption": "Standalone Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025",
      "datetime": "12-Nov-2025",
      "details": "Please find enclosed the Standalone Unaudited Financial Results for the quarter and half year ended 30th September 2025 along with the Limited Review report of the Statutory Auditors as approved by the Board of Directors at their meeting held today 12th November 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "KMC Speciality Hospitals (India) Ltd has announced <strong>12:1</strong> rights issue, ex-date: 06 Jan 11",
          "dt": "2011-01-06",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

KMC Speciality Sees Revision in Market Evaluation Amid Positive Financial Trends

2025-11-30 10:24:53

KMC Speciality has experienced a revision in its market evaluation, reflecting recent developments across its financial and operational parameters. The hospital sector stock, classified as a microcap, has demonstrated notable financial trends and valuation characteristics that have influenced this shift in market assessment.

Why is KMC Speciality falling/rising?

2025-11-25 00:35:13

Recent Price Movement and Market Context

The stock has been under pressure for the past three consecutive trading sessions, cumulatively losing 7.92% in value. This decline is significant when compared to the benchmark Sensex, which remained almost flat over the past week with a marginal 0.06% gain. The underperformance is further emphasised by the stock’s 7.31% loss over the last seven days, a stark contrast to the Sensex’s stability.

Intraday trading on 24-Nov saw the stock touch a low of ₹73.50, representing a 5.17% drop from previous levels. The weighted average price indicates that a larger volume of shares exchanged hands closer to this lower price point, suggesting selling pressure dominated the session. This pattern often signals that sellers are more aggressiv...

KMC Speciality Hospitals (India) Sees Mixed Technical Signals Amid Price Momentum Shift

2025-11-24 08:01:15

KMC Speciality Hospitals (India) has experienced a nuanced shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. The stock’s recent price momentum and technical indicators such as MACD, RSI, and moving averages reveal a landscape that demands careful analysis for investors tracking this hospital sector player.

KMC Speciality Hospitals Reports Strong Financial Metrics and Operational Effectiveness

2025-11-14 11:00:48

KMC Speciality Hospitals has reported notable financial improvements for the quarter ending September 2025, with record net sales of Rs 74.90 crore and a profit before tax of Rs 13.50 crore. The company maintains a low debt-equity ratio of 0.47, reflecting stability and effective management.

KMC Speciality Hospitals Q2 FY26: Robust Growth Momentum Continues Despite Margin Pressures

2025-11-14 09:21:57

KMC Speciality Hospitals (India) Ltd., the Tiruchirappalli-based healthcare provider, reported a standout performance for Q2 FY26, with net profit surging 43.81% quarter-on-quarter to ₹10.84 crores from ₹7.54 crores in Q1 FY26. On a year-on-year basis, profitability more than doubled, registering a remarkable 179.38% increase from ₹3.88 crores in Q2 FY25. The company's shares responded positively, advancing 2.06% to ₹79.75 on November 14, 2025, as investors digested the strong operational performance that underscored the hospital chain's expanding footprint in southern India.

Is KMC Speciality overvalued or undervalued?

2025-11-14 08:07:44

As of 13 November 2025, KMC Speciality has moved from a fair to an attractive valuation grade. The company is currently considered undervalued, especially when compared to its peers in the hospital industry. Key ratios include a PE Ratio of 41.88, an EV to EBITDA of 19.70, and a ROE of 18.51%. In comparison to peers, Apollo Hospitals has a significantly higher PE Ratio of 64.07, while Max Healthcare is even more expensive at 88.67. This suggests that KMC Speciality offers a more favorable valuation relative to its competitors. Additionally, KMC's recent stock performance has outpaced the Sensex, with a 1-week return of 12.88% compared to the Sensex's 1.40%, reinforcing the attractiveness of its current valuation....

How has been the historical performance of KMC Speciality?

2025-11-13 23:18:29

Answer: The historical performance of KMC Speciality shows a steady growth in net sales, reaching 231.60 Cr in March 2025, up from 177.18 Cr in March 2024 and 155.76 Cr in March 2023. Total operating income has followed a similar upward trend, increasing to 231.60 Cr in March 2025 from 177.18 Cr in the previous year. The company's total expenditure, excluding depreciation, also rose to 174.71 Cr in March 2025, compared to 129.79 Cr in March 2024. Operating profit, excluding other income, improved to 56.89 Cr in March 2025, while profit before tax decreased to 31.60 Cr from 40.56 Cr in March 2024. Profit after tax also saw a decline to 21.43 Cr in March 2025 from 30.38 Cr in March 2024. The earnings per share (EPS) decreased to 1.31 in March 2025 from 1.86 in March 2024. In terms of assets and liabilities, total assets increased to 286.00 Cr in March 2025 from 263.72 Cr in March 2024, while total liabiliti...

Is KMC Speciality overvalued or undervalued?

2025-11-13 08:08:23

As of 12 November 2025, KMC Speciality's valuation grade has moved from attractive to fair, indicating a shift in its perceived market value. The company appears to be fairly valued at this time, with a PE ratio of 54.51, an EV to EBITDA ratio of 22.49, and a ROE of 14.27%. In comparison to its peers, Apollo Hospitals is rated attractive with a higher PE of 64.52, while Narayana Hrudaya is considered expensive with a PE of 45.49. Despite the fair valuation, KMC Speciality's high PE ratio suggests that investors are paying a premium for its earnings relative to its peers. The stock has shown a strong performance over the past five years, with a return of 302.98%, significantly outpacing the Sensex's 94.82% return in the same period. This long-term growth may support the current valuation, but the recent downgrade in the grade suggests caution moving forward....

KMC Speciality Hospitals Adjusts Valuation Amidst Mixed Industry Performance Trends

2025-11-13 08:00:29

KMC Speciality Hospitals has recently adjusted its valuation, with its stock price reflecting a significant increase. Over the past year, the company has faced challenges, underperforming compared to the Sensex. Key financial metrics indicate operational efficiency, while comparisons with peers reveal diverse performance within the hospital industry.

View All News

Announcement

Announcement under Regulation 30 (LODR)-Newspaper Publication

26-Nov-2025 | Source : BSE

Newspaper publication regarding special window for re-lodgement of transfer request of physical shares of the Company

Announcement under Regulation 30 (LODR)-Investor Presentation

26-Nov-2025 | Source : BSE

Investor presentation for the quarter and half year ended 30th September 2025.

Standalone Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025

12-Nov-2025 | Source : BSE

Please find enclosed the Standalone Unaudited Financial Results for the quarter and half year ended 30th September 2025 along with the Limited Review report of the Statutory Auditors as approved by the Board of Directors at their meeting held today 12th November 2025.